Brief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
17/02/2026 12:39
Feb 17 (Reuters) - Kane Biotech Inc KNE.V: KANE BIOTECH ANNOUNCES FDA 510(K) CLEARANCE FOR REVYVE® ANTIMICROBIAL SKIN AND WOUND CLEANSER Source text: ID:nGNX8TdpqR Further company coverage: KNE.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update